Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found a new mutation in the FERMT1 gene in a Spanish family with Kindler syndrome.

A young man with an unusual type of scarring hair loss suggests a possible new variant of a known scalp condition.

Skin conditions like seborrheic dermatitis can make it harder to correctly diagnose hair loss because they can cause the oil glands in the skin to shrink.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Beta-blockers can cause rare skin side-effects, which usually improve after stopping the medication.

Yellow and orange colors are important for diagnosing certain skin conditions.

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Different rheumatological diseases can cause specific skin problems.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Reflectance confocal microscopy can help tell apart scarring from non-scarring hair loss.

Reflectance confocal microscopy helped diagnose and manage a woman's hair loss without needing a biopsy.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

A man's red tattoo caused a skin reaction and hair loss in his beard, which improved after treatment.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Alopecia areata in infants may be more common than previously thought.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.